Sign in

Prof Chloe Orkin

@profchloeorkin.bsky.social
3K followers 367 following 60 posts

MBE| Prof of Infection & Inequities QMUL| Director SHARE Collaborative for Health Equity| Dean for Healthcare Transformation | Co-Chair #HIVGlasgow | Ex BHIVA Chair | #HIVsky #Gender #Disabilitysky #LGBTQ+ #IDsky en.wikipedia.org/wiki/Chloe_Orkin

PostsRepliesMedia
Reposted by Prof Chloe Orkin
Harun. The poxie one. @haruntulunay.bsky.social · 10/12/2025
Have you completed the Ask Us Europe survey? For the first time, it asks about neurodiversity-and we need more autistic/ADHD voices to understand how HIV treatment is being discussed across Europe. If you’re autistic and/or have ADHD and living with HIV, please take part. bit.ly/4m5ktRm
youtu.be
Neurodiversity & HIV: Your Experience Can Change Treatment | Ask Us Europe
YouTube video by Harun Tulunay
102
Reposted by Prof Chloe Orkin
Matthew Hodson @matthewhodson.bsky.social · 17/10/2025
The Ask Us Europe team at #EACS2025 following Megan’s poster presentation. If you’re on HIV treatment and live in Europe, please take part - it takes 10 minutes and the results should help improve treatments for us. @shareeastlondon.bsky.social @profchloeorkin.bsky.social bit.ly/4oqzvCG
Me, Angelina, Megan, Chloe and Chloe of SHARE Research Collaborative at EACS. We’re all smiling.
1195
Reposted by Prof Chloe Orkin
Barts Charity @bartscharity.bsky.social · 28/11/2025
Well done to @profchloeorkin.bsky.social & @shareeastlondon.bsky.social. They won the Impact-led Initiative Award at @knowledgeexchange.bsky.social Awards for their inclusive response to the Mpox outbreak. @qmul.bsky.social @qmulfmd.bsky.social
131
Reposted by Prof Chloe Orkin
Queen Mary University of London @qmul.bsky.social · 28/11/2025
Huge congratulations to @profchloeorkin.bsky.social and the @shareeastlondon.bsky.social for winning the Impact led Initiative Award at the KE Awards. A brilliant recognition of community driven mpox research and partnership working. Full story: www.qmul.ac.uk/media/news/2...
242
Reposted by Prof Chloe Orkin
hideta77.bsky.social @hideta77.bsky.social · 13/08/2025
Pleased to inform that a consortium of Japanese doctors has published a paper on LAI. I’m honored to be listed as a co-author. Prof. Orkin encouraged us to form the consortium. We appreciate your support. @profchloeorkin.bsky.social @toshtaniguc.bsky.social onlinelibrary.wiley.com/doi/10.1111/...
onlinelibrary.wiley.com
Evaluation of cabotegravir plus rilpivirine in routine clinical settings in Japan: A multicentre study of efficacy, safety and biomarker dynamics
Objectives Long-acting cabotegravir plus rilpivirine (CAB+RPV) offers an alternative to daily oral therapy, but real-world data in East Asia remain scarce. This study aims to evaluate the impact of ...
031
Reposted by Prof Chloe Orkin
UK-CAB @ukcab.bsky.social · 06/08/2025
We encourage all people living with HIV in Europe to join this short study run by @shareeastlondon.bsky.social & @profchloeorkin.bsky.social to share their experiences with new HIV treatments & conversations with the clinical teams about treatment choices. Visit the page & complete the survey below
035
Prof Chloe Orkin @profchloeorkin.bsky.social · 23/07/2025
Are you: ✅working in a UK sexual health service that provides #PrEP, AND ✅willing to take part in a 15 minute survey? We are conducting a brief survey of sexual health clinics for our #beyondtheclinic study. You can complete the survey here: bit.ly/40weNaX #studyparticipants
bit.ly
Beyond the Clinic Survey | SHARE Research Collaborative
A survey to understand the breadth and scale of issues which may impact equitable implementation of CAB-LA outside of sexual health clinics in the UK.
122
Reposted by Prof Chloe Orkin
Matthew Hodson @matthewhodson.bsky.social · 22/07/2025
Do you live with HIV? Are you in Europe and currently on treatment? Please take part in the Ask Us Europe survey, which aims to improve treatment and care for people with HIV. I am proud to have worked on it with @shareeastlondon.bsky.social and a powerful group of people with HIV. Please share. 🙏
Flyer for the Ask Us Europe study, including a QR code. I will add the link to the survey in a post that I will thread to this one.
22634
Prof Chloe Orkin @profchloeorkin.bsky.social · 22/07/2025
Our latest study to understand the perspective of people living with HIV in Europe is now live! We created it together with an amazing steering group of community members from 17 countries. Please do the survey if you are living with HIV in UK and Europe and SHARE widely !! 🙏🙏🙏🙏
055
Reposted by Prof Chloe Orkin
WHO @who.int · 27/03/2025
A decline in funding for the HIV response could result in millions of preventable new infections and deaths, with up to 120,000 of these deaths affecting children. International cooperation is essential to sustain the advances we’ve made in HIV prevention, testing, and treatment. bit.ly/43uTfxA
10 million potential new HIV infections by 2030; 3 million potential more deaths, including 120,000 children, due to HIV-related causes by 2030. This could be the impact of HIV funding cuts.
25969365
Reposted by Prof Chloe Orkin
BK. Titanji @boghuma.bsky.social · 24/03/2025
🚨1.25 million people died of TB in 2023 🚨10.8 million new cases of TB were diagnosed in 2023 🚨Multi-drug resistant TB is a public health crisis 🚨US$ 22 billion is needed annually for TB prevention, diagnosis, treatment and care, but funding is being cut. 🚨Poverty fuels TB globally #WorldTBDay2025
415963
Prof Chloe Orkin @profchloeorkin.bsky.social · 20/03/2025
#DEI , women’s rights, LGBTQ+ rights, disability rights, global & domestic public health are under attack and being censored in the US. Let’s remember the phenomenon of ‘social contagion’ -the concept that thoughts 💭 can be as contagious as viruses 🦠 and keep committing to celebrating #DEI 🏳️‍🌈🏳️‍⚧️✊🏿♿️
Photo of woman with purple hair and rainbow t shirt. 
Text reads : Queen Mary
University of London
Celebrating Women's History
Month
'Stories of everyday sexism and sexual harassment appear almost daily in the news because sexism and harassment continue to be perpetrated in the workplace with depressing frequency.
That's why celebrating women who speak up and beat a better path for those who follow them continues to be relevant.'
051
Prof Chloe Orkin @profchloeorkin.bsky.social · 12/03/2025
Re-suppression post CAB LA PrEP 083 #CROI2025 9/44 had INSTI resistance before ART 6/6 people suppressed on INSTIs (VL less than / equal to 50 c/ML) 15/16 on other ART 5 further participants from other oral regimens switched to INSTIs afterwards and maintained suppression where data available.
050
Prof Chloe Orkin @profchloeorkin.bsky.social · 12/03/2025
Very strong data from the PILLAR study LA CAB PrEP #CROI2025 60% were cis BiPOC men and were 6% trans men •201 people •0 transmissions •High retention and coverage •22% had not taken PrEP in past 3/12
041
Prof Chloe Orkin @profchloeorkin.bsky.social · 12/03/2025
Brazilian CAB PrEP cohort #CROI2025 •genXpert test at baseline •diverse cohort •86% chose CAB LA •CAB adherence very high •PREP coverage much higher than oral PrEP •no incident infections on CAB •6% did not persist on CAB • 4% switched away due to side effects
0111
Prof Chloe Orkin @profchloeorkin.bsky.social · 12/03/2025
Very strong data on LA CAB PrEP from Kaiser Permanente large US real world cohort #CROI2025: •141 received LA CAB •25% had never taken PrEP •75% persistence •No incident infections •> 90% of injections given on time
090
Reposted by Prof Chloe Orkin
WHO @who.int · 12/03/2025
✅ WHO does not impose lockdowns or policies on countries. It does not have the authority to do this and isn't trying to get it. Only governments can make those decisions. Know the facts ⬇️
8646112
Prof Chloe Orkin @profchloeorkin.bsky.social · 11/03/2025
ARV session highlights #CROI2025: •Once yrly LEN dose tolerable with good PK •VH499 (capsid inhibitor) with LA potential led to rapid resistance at lowest dose •VH184 3rd gen INSTI appears potent against multiple mutations •ZAB/TAB/LEN-1 breakthru VF (low LEN levels & single bNAb susceptibility)
1121
Prof Chloe Orkin @profchloeorkin.bsky.social · 10/03/2025
For those at #CROI2025 there is a ‘Save our Science’ rally this evening at Yerba gardens next to the Moscone centre Non US people CAN attend but you won’t be able to register Hope to see you there @iasociety.bsky.social @hivpxresearch.bsky.social @bhiva.bsky.social
0117
Prof Chloe Orkin @profchloeorkin.bsky.social · 09/03/2025
Post from #CROI2025 San Francisco: I have been re-posting recently to amplify voices of US colleagues on the war on science and public health that is taking place in the US and the cuts to public funding for PEPFAR HIV programmes supporting treatment and HIV prevention for millions worldwide.
1328
Prof Chloe Orkin @profchloeorkin.bsky.social · 08/03/2025
Happy IWD to all the wonderful, wise women I am so fortunate to have in my life - first and foremost my wife of 24 years, my friends, my colleagues and fellow human rights activists.
1171
Reposted by Prof Chloe Orkin
WHO @who.int · 07/03/2025
Violence against women demands urgent attention. One in three women faces physical or sexual violence, and nearly 25% of workplace violence happens in hospitals or clinics — and women are most affected. #BeijingPlus30 #IWD2025
1 in 3 women worldwide experiences physical or sexual violence.
8830256
Prof Chloe Orkin @profchloeorkin.bsky.social · 27/02/2025
Here is a blog by Vanessa Apea and I describing the story behind most recent SHARE-net manuscript on the healthcare provider perspective during the 2022/23 #mpox outbreak. The paper has been published in PLOS Global Public Health eur01.safelinks.protection.outlook.com?url=https%3A...
eur01.safelinks.protection.outlook.com
Behind the Paper: International Healthcare Workers’ Experiences and Perceptions of the 2022 Mpox Outbreak
PLOS Global Public Health was a natural home for our study due to its commitment to open-access publishing and its focus on amplifying research from diverse and resource-limited settings. Given the gl...
142
Reposted by Prof Chloe Orkin
European Centre for Disease Prevention and Control @ecdc.europa.eu · 17/02/2025
Check out our latest #CDTR - the weekly bulletin for epidemiologists and public health professionals with updates on: ➡️ #STIs ➡️ #chikungunya ➡️ #Ebola ➡️ #measles ➡️ #AvianInfluenza ➡️ #SwineInfluenza ➡️ #influenza & respiratory virus epidemiology. Read full here: bit.ly/41iaY9P #IDsky #EpiSky
bit.ly
Communicable disease threats report, 8 - 14 February 2025, week 7
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 8-14 February and includes updates on STI cases, chikungunya, Ebola, measles, avian influenza A (H9N2, H5N1), swine ...
02212
Prof Chloe Orkin @profchloeorkin.bsky.social · 16/02/2025
In these unthinkably dark days for global public health I’m proud to share the results of this international survey which describes the challenging and distressing experiences of clinicians in 12 countries during the 2022/23 #mpox pandemic. eur01.safelinks.protection.outlook.com?url=https%3A...
eur01.safelinks.protection.outlook.com
International healthcare workers’ experiences and perceptions of the 2022 multi-country mpox outbreak
In May 2022, the most widespread outbreak of sustained transmission of mpox outside of countries historically affected countries in Western and Central Africa occurred. We aimed to examine the persona...
23513
Prof Chloe Orkin @profchloeorkin.bsky.social · 04/02/2025
010
Reposted by Prof Chloe Orkin
Carl Zimmer @carlzimmer.com · 28/01/2025
The PEPFAR program, which distributes HIV drugs, is estimated to have saved 25 million lives. The Trump administration has stopped it and taken its computer system offline, raising fears the program is done for good. Story by @apoorvanyt.bsky.social [Gift link] nyti.ms/4aCJHSx 2/12
nyti.ms
Trump Administration Halts H.I.V. Drug Distribution in Poor Countries (Gift Article)
PEPFAR’s computer systems also are being taken offline, a sign that the program may not return, as Republican critics had hoped.
7361133
Prof Chloe Orkin @profchloeorkin.bsky.social · 04/02/2025
It is important to follow the threat to science as it unfolds in the US. See the thread below
111
Reposted by Prof Chloe Orkin
Queen Mary Faculty of Medicine & Dentistry @qmulfmd.bsky.social · 31/01/2025
Fantastic to see this profile of our Professor of Infection and Inequities! Congratulations, @profchloeorkin.bsky.social
031
Prof Chloe Orkin @profchloeorkin.bsky.social · 31/01/2025
Thanks QMUL for highlighting this Lancet profile of my work. I’m very honoured to have been profiled & very grateful it foregrounded my work outside of the biomedical model of health & disease & beyond high impact papers. She foregrounded the activism & inclusion work I am most proud of.
094
Reposted by Prof Chloe Orkin
SHARE Collaborative @shareeastlondon.bsky.social · 22/01/2025
Excited to share a new research paper (open access) from our collaboration with @thelovetankcic.bsky.social and the HIV/STI and Emergency Preparedness teams at @who.int.bsky.social doi.org/10.1186/s129...
doi.org
“If that would have lessened my symptoms, that would have been great...”: a qualitative study about the acceptability of tecovirimat as treatment for mpox - BMC Medicine
Background Tecovirimat, an antiviral treatment for smallpox, was approved as a treatment for mpox by the European Medicines Agency in January 2022. Approval was granted under “exceptional circumstance...
176
Prof Chloe Orkin @profchloeorkin.bsky.social · 10/12/2024
US based STOMP trial of tecovirimat (tpoxx) for clade 2 mpox fails to demonstrate efficacy benefit. Just as it did not in PALM 007 in clade 1 mpox in DRC. There is no known treatment for mpox Vaccination is the key control strategy and more research is needed. pubmed.ncbi.nlm.nih.gov/38190312/
pubmed.ncbi.nlm.nih.gov
Early Tecovirimat Treatment for Mpox Disease Among People With HIV - PubMed
Results of this cohort study support starting tecovirimat in all PWH as soon as an mpox diagnosis is suspected. Additional research is warranted to confirm these findings.
0177
Prof Chloe Orkin @profchloeorkin.bsky.social · 27/11/2024
Kamakura Japan 🇯🇵 - an Autumn/ Fall spectacle to behold 🍁🍂.
A nature scene:
Dark vertical tree trunks are separated by patches of bright Autumn foliage in red, amber and yellow and green leaves.
060
Prof Chloe Orkin @profchloeorkin.bsky.social · 23/11/2024
Bluesky 🦋 etiquette question: Is it ok to post photos of trees in the good place? @brendacrabtreer.bsky.social @cla-cor.bsky.social
8142
Prof Chloe Orkin @profchloeorkin.bsky.social · 21/11/2024
Wonderful to see this incredibly important work foregrounded. Delighted to see @shareeastlondon.bsky.social Dr’s Vanessa Apea and Rebecca Mbewe playing a leading role.
082
Prof Chloe Orkin @profchloeorkin.bsky.social · 19/11/2024
This is so brilliant! Had to repost this from the inimitable @paulsaxmd.bsky.social
1102
Reposted by Prof Chloe Orkin
Darcy Wooten (she/her) @darcy-id-doc.bsky.social · 18/11/2024
Be sure to join @profchloeorkin.bsky.social and me today as we discuss the latest in HIV treatment and prevention!
273
Reposted by Prof Chloe Orkin
Ilan Schwartz @germhuntermd.bsky.social · 16/11/2024
Cementing the professional legitimacy of 🦋 We now have the journals on #MedSky & #IDSky @jamacurrent.bsky.social @bmj.com @cmicomms.bsky.social (first one?) @eurosurveillance.bsky.social @cidjournal.bsky.social @ofidjournal.bsky.social @thejhi.bsky.social @jclinical-invest.bsky.social
24279104
Prof Chloe Orkin @profchloeorkin.bsky.social · 16/11/2024
Monday, November 18, 2024 1:00 PM - 2:00 PM Eastern Time (ET) Darcy Wooten and I will be summarising keyHIV studies affecting my practice from IDWeek and Glasgow 2024 for CCO. Join us for this live, interactive webinar CCO doesn’t seem to be on Bluesky yet so check their website.
152
Prof Chloe Orkin @profchloeorkin.bsky.social · 15/11/2024
In addition to skeeting about #HIV #mpox and #inequities and infections, my ‘side hustle’ is speaking up and writing about hidden #disability. Here is my first self-reflective piece published in BMJ Leader #DisabilitySky bmjleader.bmj.com/content/7/2/88
bmjleader.bmj.com
Reflections and intersections: disability, ‘ableism’ and metamodern leadership
In this article the author, the eightieth President of the Medical Women’s Federation and a clinical academic, reflects on disability, gender, and leadership. She draws on lessons from her sixteen-yea...
191
Reposted by Prof Chloe Orkin
BK. Titanji @boghuma.bsky.social · 14/11/2024
Important editorial! "Women's ability to take a full part in education, to have equal access to health care, to make their own decisions, to have fairly paid work, and to be elevated to positions of authority are fundamental rights that no one should question." www.thelancet.com/journals/lan...
thelancet.com
Fixing the system to end violence against women
In November 2023, we published a study reporting that, at a global level, the pervasive issue of intimate partner violence (IPV), one of the most common types of violence against women, was beginning ...
19722
Prof Chloe Orkin @profchloeorkin.bsky.social · 14/11/2024
We’re very excited to announce that @shareeastlondon.bsky.social first manuscript from the ILANA study has been published in CIDJournal! You can view it here (open access): doi.org/10.1093/cid/...
doi.org
Perspectives of people with HIV on implementing long acting cabotegravir plus rilpivirine in clinics and community settings in the UK: results from the anti-sexist, anti-racist, anti-ageist ILANA stud...
When offered the choice to receive CAB+RPV injections in the community, most participants declined. Key concerns related to anticipated stigma, inconvenien
1103
Prof Chloe Orkin @profchloeorkin.bsky.social · 13/11/2024
New EACS guidance on cancer screening at #HIVGlasgow Screen MSM and TGW>35 and all other men >45 Women >21yrs annually or 3-yearly after three neg PAP smears with CD4 >350 undetectable Tristan Barber asks how this will be achieved with limited capacity
2154
Prof Chloe Orkin @profchloeorkin.bsky.social · 13/11/2024
First ever EACS guidelines on chemsex #HIVGlasgow Ask: Do you consume drugs before or during planned sex to facilitate, initiate, prolong, sustain and intensify the encounter? Do you want to see questionnaire score, risk reduction advice and assess level of concern with use @bhiva.bsky.social
2167
Reposted by Prof Chloe Orkin
BK. Titanji @boghuma.bsky.social · 12/11/2024
CDC 2023 STI report just published today 📌2.4 million STIs reported in the United States in 2023; 📌Gonorrhea ⬇️ by 7% from 2022. 📌Syphilis ⬆️ by only 1% 📌 congenital syphilis increased by 3% . Improving trends but still to high, especially congenital syphilis rates www.cdc.gov/sti-statisti...
cdc.gov
Sexually Transmitted Infections Surveillance, 2023
The most recent national data for reportable STIs: chlamydia, syphilis, gonorrhea.
36023
Prof Chloe Orkin @profchloeorkin.bsky.social · 12/11/2024
HIV CURE: Karine Dube asks : do we need to build in an offer of PrEP to partners of participants of ATI ( analytical treatment interruption) studies ? #HIVGlasgow @bhiva.bsky.social @tristanjbarber.bsky.social
052
Prof Chloe Orkin @profchloeorkin.bsky.social · 12/11/2024
Karine Dube : Ethics of cure- favourable risk/balance ratio. Risks: social, financial, psychological or physical Analytical treatment interruptions affect mental health. Bear in mind: disappointment or stigma associated with viraemia may occur. Calls for justice-informed ATI #HIVGlasgow
0100
Prof Chloe Orkin @profchloeorkin.bsky.social · 12/11/2024
#HIVGlasgow @drlaurajwaters.bsky.social shows systematic review of adverse events on statins. Helpful ++ for shared-decision making with PLWH. She mentions potential benefit in vascular dementia and that muscle aches can resolve if statin continued. BHIVA recommends statins for PLWH > 40 yrs
White woman with blond hair and black dress with red lips shows slide covering a systematic review on statin side effects versus placebo:
It shows that main side effects on are similar to what would occur on a placebo ( myalgia, liver and diabetes).
0124
Prof Chloe Orkin @profchloeorkin.bsky.social · 12/11/2024
Happy share to evidence synthesis work from @shareeastlondon.bsky.social on re-suppression regimens post CAB+RPV from RCT and RWE and on CVF events from RWE #HIVGlasgow 13 cohorts : CVF was <2% in cohorts with> 75 participants Commonest Post VF regimens RCTs :mostly PI RWE CAB RPV continuation
051
Prof Chloe Orkin @profchloeorkin.bsky.social · 11/11/2024
Hi everyone I have just fled X. I tweet about #HIV #mpox # gender #LGBTQ+ rights #disability rights #inclusion in trials
46010